The invention relates to an
active oxygen degradable polydiacetylene
prodrug as well as preparation and application thereof, and belongs to the technical field of medicines. By utilizing the unique property that a main chain of a polydiacetylene
polymer is completely broken into carboxyl-containing small molecules when the
active oxygen level is increased, a carboxyl-containing
drug is used as a
raw material to construct a polydiacetylene
prodrug, so that long-acting on-demand
drug release of
active oxygen response is realized. According to the
prodrug, active
oxygen is utilized to trigger a conjugated main chain to break so as to release an active
drug, and meanwhile, a biocompatible
small molecule by-product is generated. According to the polydiacetylene
polymer side chain covalent connection
medicine carrying
system, the phenomenon of burst release of the
medicine is effectively avoided, continuous administration as long as several months is achieved, and the polydiacetylene
polymer side chain covalent connection
medicine carrying
system has high focus
site selectivity and extremely low
systemic toxicity. The active
oxygen responsive
degradation process and
drug release cooperate to play a therapeutic role, and a
negative feedback regulation
drug release loop is formed, so that excessive administration and
whole body exposure are avoided, on-demand remodeling of a microenvironment is realized, and the
therapeutic effect is improved.